Tech Company Financing Transactions

Swift Biosciences Funding Round

Swift Biosciences closed a $7 million Series B funding round on 10/17/2013. Investors included Fletcher Spaght Ventures, Mercury Fund and Michigan Accelerator Fund.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

674 S. Wagner Rd. 100
Ann Arbor, MI 48103
USA

Phone

(734) 330-2568

Website

www.swiftbiosci.com

Email Address

[email protected]

Overview

Swift Biosciences is developing molecular biology reagents for research and diagnostic applications.Our products help users to detect genes and gene products that other products can't. We also help users to analyze their samples faster, at higher volume, and at a lower price-per-sample.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Nathan Wood

        

Chief Financial Officer

James Militello

        

Chief Scientific Officer

Vladimir Makarov

        

VP - Marketing

Camille Cappello

        

VP - Product Management

Laurie Kurihara

        

VP - Sales

Haley Fiske

        

Browse more venture capital transactions:

Prev: 10/16/2013: mParticle venture capital transaction
Next: 10/17/2013: Binary Event Network venture capital transaction

Share this article

About Database of VC Transactions

We do our best to document every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary